NPSGF yields 62.89% · JNJ yields 2.13%● Live data
📍 NPSGF pulled ahead of the other in Year 1
Combined, NPSGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NPSGF + JNJ for your $10,000?
Nippon Sheet Glass Company, Limited manufactures and sells glass and glazing products worldwide. It operates through Architectural, Automotive, Technical Glass, and Other segments. The company offers architectural products, including solar control, thermal insulation, fire protection, noise control, safety/security, self-cleaning, decoration, solar energy, and antimicrobial glasses; glass systems; and coated or non-coated glasses the Pilkington brand. It also provides automotive products, such as automotive glass products for vehicle original equipment manufacturers; aftermarket glass replacement products; and glass solutions for specialized vehicles, which include commercial, off-road, bus and coach, marine, and rail. In addition, the company offers functional products under the MICROGLAS, Flake, Metashine, GLASFLAKE, and SILKYFLAKE names; absorbent glass mat (AGM) separator, a component for valve regulated lead-acid batteries; polyethylene (PE) separator, which allows the battery assembly line to run efficiently; and sleeve tubes, which are used as the separators for positive plate of clad type lead-acid batteries. Further, it provides SELFOC lens arrays and micro lenses; SELGUIDE, a linear LED light source for image scanning; sheet glasses for electronic office devices; and ultra-fine flat glasses. The company was formerly known as America Japan Sheet Glass Co., Ltd. and changed its name to Nippon Sheet Glass Company, Limited in 1931. Nippon Sheet Glass Company, Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.
Full NPSGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.